Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-01

Clinical Trial Update: Aripiprazole in Adolescents With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial of aripiprazole in adolescents with schizophrenia completed. Results were posted in August 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-08-01